Fracture Risk Evaluation of Bone Metastases Derived From Carcinoma
ConditionBone Metastases
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorCostantino Errani
About this trial
From the archives of the Rizzoli institute all patients (approximately 750) treated for bone metastases from 01/01/2010 to 31/12/2022.
A review will be made from the medical records, radiological imaging, and histological data of these patients
Eligibility criteria
Qualifiers
Age ≥ 18 years
Diagnosis of bone metastasis from carcinoma, regardless of the type of carcinoma, and of the number and location of the metastases
Availability of imaging and clinical data
Availability of at least one follow-up during the last 12 months form diagnosis
Disqualifiers
At least one inclusion creteria not met
Trial design
Treatments tested in this trial
- Analysis
Treatment groups
250 Participants
are divided into 1 treatment groupSponsors and collaborators
Costantino Errani
Lead sponsor
Istituto Ortopedico Rizzoli
Sponsor institution
Source ClinicalTrials.gov